Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Glancy Binkow & Goldberg LLP announces that all persons or entities who purchased the securities of K-V Pharmaceutical Company...
Law Offices of Howard G. Smith, representing investors of K-V Pharmaceutical Company (“K-V" or the “Company”) (NYSE:KV-A...
Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for...
Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust...
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the...
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of purchasers of the common stock...
Zeldes & Haeggquist, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into possible...
K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call PR Newswire ST. LOUIS, June 13, 2011...
K-V Pharmaceutical Company Announces $200 Million Private Debt Offering PR Newswire ST. LOUIS, March 1, 2011 ST. LOUIS, March 1, 2011...
KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call Comments PR Newswire ST. LOUIS, Feb. 14...
K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue Warrants in...
K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock COMPANY ANNOUNCES AGREEMENT OF TERMS...
K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011 PR Newswire ST. LOUIS, Feb. 4, 2011 ST. LOUIS, Feb. 4, 2011...
K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™ PR Newswire ST. LOUIS, Jan. 12, 2011 ST. LOUIS, Jan. 12, 2011...
ST. LOUIS, Feb. 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) ("the Company") today announced that it has reached an...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지